Fertility drug choice may impact IUI success, large study suggests

NCT ID NCT03669276

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study reviewed 1251 intrauterine insemination (IUI) cycles at one hospital to see if the type of fertility drug used or the cause of infertility affected pregnancy rates. Participants were women aged 20-44 with normal ovulation and their partners with adequate sperm. The researchers looked at clinical pregnancy and live-birth rates, aiming to identify factors that lead to better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: gonadotropins (recombinant FSH, urinary FSH, or hMG)
What this could lead to: If successful, this could help doctors choose the best ovarian stimulation drug for each couple, potentially improving IUI success rates.
What could go wrong: This is a retrospective review, not a controlled trial, so results may not prove cause and effect. Findings may not apply to all fertility clinics or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY

Contacts and locations

Locations

CHU Amiens-Picardie

Amiens, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.